Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Anixa Biosciences Inc (NQ: ANIX ) 3.660 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Anixa Biosciences Inc < Previous 1 2 Next > 12 Health Care Stocks Moving In Wednesday's After-Market Session October 30, 2024 Via Benzinga Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying July 29, 2024 Via Benzinga EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy July 23, 2024 FDA Approves Anixa Biosciences' Ovarian Cancer CAR-T Therapy for Individual Patient Trial. Moffit Cancer Center receives approval for a second dose in an ongoing Phase I trial showing early promising... Via Benzinga Exposures Product Safety EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program July 15, 2024 Anixa Biosciences announces $5 million share repurchase program due to undervalued stock. Partnership with Cleveland Clinic for cancer vaccines. Via Benzinga ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 June 04, 2024 ANIX stock results show that Anixa Biosciences beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Recap: Anixa Biosciences Q1 Earnings March 12, 2024 Via Benzinga 6 Analysts Have This to Say About Anixa Biosciences June 19, 2023 Via Benzinga The Latest Analyst Ratings for Anixa Biosciences May 23, 2023 Via Benzinga Expert Ratings for Anixa Biosciences April 18, 2023 Via Benzinga 7 Penny Biotech Stocks to Triple Your Investment May 28, 2024 Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns. Via InvestorPlace Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape? December 20, 2023 Anixa Biosciences (NASDAQ: ANIX) is an interesting, undiscovered biotech company that seeks to disrupt the cancer landscape by working with some highly credible partners. The company is undiscovered... Via Benzinga 3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 December 11, 2023 Some of the most explosive opportunities can be found in biotech stocks. In fact, as we head into New Year 2024, here are three to consider. Via InvestorPlace Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations' December 07, 2023 Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 07, 2023 Via Benzinga The 3 Most Undervalued Cheap Stocks to Buy in September 2023 September 11, 2023 These cheap stocks to buy are the ones for long term growth and high returns in your investment portfolio. Via InvestorPlace Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer? August 09, 2023 Cancer is a disease that affects millions of people around the world. Historically, cancer vaccines have not been very successful in treating or preventing the disease. However, recent research on the... Via Benzinga Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying July 24, 2023 The Dow Jones edged higher on Friday, recording gains for the tenth straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session February 23, 2023 Via Benzinga Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals December 27, 2022 Kathleen Moriarty, the lawyer who helped develop the structure for SPY and a true co-founder of the ETF industry, passed away last week. Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022 December 23, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session December 09, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session October 10, 2022 Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 16, 2022 Via Benzinga Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday September 19, 2022 Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. Via Benzinga Recap Of Monday's Biotech Catalysts - End Of the Day Summary August 15, 2022 Via Benzinga Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study August 15, 2022 Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer. Via Benzinga Can The Cure For Cancer Lie In Vaccines? August 11, 2022 Despite a global pandemic and war brimming in Europe, cancer remains the world’s second-deadliest killer in the world, taking over 600,000 lives Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 26, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 29, 2022 Via Benzinga 70 Biggest Movers From Friday May 02, 2022 Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
